Timetable 2022

Wednes­day 28.09.2022

15.00 – 15.15 Offi­cial Open­ing (Michał Malewicz, Łukasiewicz — PORT)

Ses­sion 1 — Bio­log­i­cal basis for can­cer (Rare diseases)

15.15 — 15.50 Piotr Donizy (Wro­claw Med­ical Uni­ver­si­ty, Poland, online), Merkel cell car­ci­no­ma (MCC) — an ultra-rare and high­ly aggres­sive skin can­cer: unmet needs and chal­lenges in 2022

15.50 — 16.25 Agi Grigo­ri­adis (King’s Col­lege Lon­don, UK), Tar­get­ing tran­scrip­tion­al and sig­nal­ing path­ways in osteosar­co­ma patho­gen­e­sis and metastasis

16.25 — 17.00 Lucy Yates (Well­come Trust Sanger Insti­tute, UK), Spa­tial genomics maps the struc­ture, char­ac­ter and evo­lu­tion of can­cer clones

17.00 — 17.35 Sus­sane Schli­sio (Karolin­s­ka Insti­tute, Swe­den), Explor­ing dri­vers phe­no­typ­ic plas­tic­i­ty in pheochro­mo­cy­toma, para­gan­glioma and neu­rob­las­toma progression

17:35 — 18.00 Break

18.00 — 19.00 Open­ing Keynote: Boże­na Kamińs­ka-Kacz­marek (Nenc­ki Insti­tute, Poland), Dis­sect­ing immune microen­vi­ron­ment of gliomas at sin­gle-cell res­o­lu­tion allows for repro­gram­ming of tumor microen­vi­ron­ment and improves immunotherapy

Thurs­day 29.09.2022

Ses­sion 2 — Bio­log­i­cal basis for can­cer (DDR)

09.00 — 09.35 Mał­gorza­ta Kra­jew­s­ka (Uni­ver­si­ty Col­lege Cork, Ire­land), Tar­get­ing Cyclin-depen­dent kinas­es for can­cer therapy

09.35 — 10.10 Rachael Natra­jan (Insti­tute of Can­cer Research, UK), Tar­get­ing SF3B1 mutant cancers

10.10 — 10.45 Özdemirhan Serçin (Bio­Med X, Ger­many), PARIS: A machine learn­ing approach to find Syn­thet­ic Lethal Inter­ac­tions in DNA Repair for Per­son­alised Can­cer Therapy

10.45 — 11.20 Break

Ses­sion 3 — Pre­ci­sion ther­a­pies in oncol­o­gy (Immuno-oncol­o­gy I)

11.55 Gabriela Kramer-Marek (Insti­tute of Can­cer Research, UK), Pho­toim­munother­a­py — from bench to bedside

11.55 — 12.30 Shee­ba Irshad (King’s Col­lege Lon­don, UK), Map­ping the Immune Land­scape of High-Risk Chemother­a­py Resis­tant Breast Cancers

12.30 — 13.05 Adri­an Hay­day (King’s Col­lege Lon­don, UK), IMMUNE SUR­VEIL­LANCE OF CELL PATHOL­O­GY IN CAN­CER and COVID-19: from the clin­ic to the bench and back to the clinic

13.05 — 14.15 Break

Ses­sion 4 — Pre­ci­sion ther­a­pies in oncol­o­gy (WIB-spon­sored session)

14.15 — 14.50 WIB pre­sen­ta­tion 1 — Prof. Andrzej Dziem­bows­ki (IIM­CB, Poland), Onco­genic mech­a­nisms of DIS3 mutations

14.50 — 15.25 WIB pre­sen­ta­tion 2 — Prof. Jacek Jemieli­ty (UoW, Poland), Chem­i­cal­ly Mod­i­fied mRNA for Ther­a­peu­tic Applications

15.25 — 16.00 Piotr Kowal­s­ki (Uni­ver­si­ty Col­lege Cork, Ire­land), Engi­neer­ing mes­sen­ger RNA nan­oth­er­a­peu­tics for can­cer therapy

16.00 — 16.35 Ivano Ame­lio (Uni­ver­si­ty of Kon­stanz, Ger­many), P53 pre­vents genom­ic insta­bil­i­ty pre­serv­ing epi­ge­net­ic integrity

16.35 — 17.00 Break

17.00 — 18.00 Keynote lec­ture: Stephen Schoen­berg­er (La Jol­la Insi­tute for Immunol­o­gy, USA), Found in Trans­la­tion: Enabling Per­son­al­ized Immunother­a­py through

Academic/​Clinical alliances

Fri­day 30.09.2022

Ses­sion 5 — Pre­ci­sion ther­a­pies in oncol­o­gy (Immuno-oncol­o­gy II)

09.30 — 10.05 Richard Beat­son (Uni­ver­si­ty Col­lege Lon­don, UK, online), Gly­co-immuno-reg­u­la­tion of epithe­lial disease

10.05 — 10.40 Grze­gorz Chodaczek (Łukasiewicz — PORT, Poland), Anti-can­cer activ­i­ty of ex vivo expand­ed yō T cells against glioblas­toma multiforme

10.40 — 11.00 Break

Ses­sion 6 — Diag­nos­tics in oncol­o­gy (Bio­mark­ers, new diag­nos­tic methods/​computational AI pathology)

11:00 — 11.35 Tomasz Zal (Immat­ics, USA), The tumor microen­vi­ron­ment in immunother­a­py design and diag­nos­tics — a per­son­al journey

11.35 — 12.10 Ani­ta Grigo­ri­adis (King’s Col­lege Lon­don, UK), Machine learn­ing ‑based approach­es cap­ture nov­el prog­nos­tic mor­pho­log­i­cal fea­tures in triple neg­a­tive breast can­cer patients

12:10 — 12.45 Rober­to Sal­ga­do (Uni­ver­si­ty Hos­pi­tal of Antwerp, Bel­gium), How can mor­pho­log­i­cal eval­u­a­tion of the immunesys­tem help in trans­la­tion­al research?

12.45 — 13.20 Piotr Ziółkows­ki (Wro­claw Med­ical Uni­ver­si­ty, Poland) / Krzysztof Żół­tańs­ki (Via­lu­tions, Poland) / Andreas Pohling (Via­lu­tions, Poland), New IT solu­tion for guid­ed report­ing for pathol­o­gists diag­nos­ing breast tumors

13:20 Offi­cial closure